| Name | Title | Contact Details |
|---|
Procyrion is developing the first catheter-deployed circulatory assist device intended for long-term use. The Procyrion device will be the first minimally invasive tool for cardiologists to treat over 1M NYHA Class III and early class IV heart failure (HF) patients in the US who have few therapeutic options. In partnership with Texas Heart Institute, Procyrion is currently conducting preclinical testing of the Procyrion device.
NXC Imaging is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hospitality Dental Group is a Palm Desert, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Biosense Webster is offering you exposure to the best-in-class AF* practices through our Centers of Excellence program. Our Centers of Excellence provide you with the opportunity to fine tune your approach to PAF ablation by observing cases at
Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to helping patients live better.